Zhe Yang

947 total citations
42 papers, 656 citations indexed

About

Zhe Yang is a scholar working on Molecular Biology, Oncology and Surgery. According to data from OpenAlex, Zhe Yang has authored 42 papers receiving a total of 656 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 13 papers in Oncology and 12 papers in Surgery. Recurrent topics in Zhe Yang's work include Cancer-related molecular mechanisms research (6 papers), Ferroptosis and cancer prognosis (4 papers) and Cancer, Hypoxia, and Metabolism (4 papers). Zhe Yang is often cited by papers focused on Cancer-related molecular mechanisms research (6 papers), Ferroptosis and cancer prognosis (4 papers) and Cancer, Hypoxia, and Metabolism (4 papers). Zhe Yang collaborates with scholars based in China, Madagascar and Ethiopia. Zhe Yang's co-authors include Zihan Yi, Yingmin Kuang, Shusen Zheng, Yuechun Zhu, Qiaoqiao Han, Lin Zhou, Tianchi Chen, Haiyang Xie, Qiao Zhang and Bingyi Lin and has published in prestigious journals such as SHILAP Revista de lepidopterología, Biomaterials and Biochemical and Biophysical Research Communications.

In The Last Decade

Zhe Yang

37 papers receiving 648 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Zhe Yang China 15 407 280 135 101 81 42 656
Guangyang Yu China 13 580 1.4× 261 0.9× 221 1.6× 90 0.9× 86 1.1× 17 761
Jingjing Zeng China 15 395 1.0× 243 0.9× 96 0.7× 139 1.4× 66 0.8× 52 675
Yingxi Mo China 16 393 1.0× 280 1.0× 107 0.8× 59 0.6× 51 0.6× 36 580
Chuanyong Zhang China 13 382 0.9× 231 0.8× 156 1.2× 49 0.5× 125 1.5× 25 630
Hubin Yin China 18 613 1.5× 377 1.3× 101 0.7× 155 1.5× 91 1.1× 29 886
Xiaoqian Jing China 19 442 1.1× 221 0.8× 185 1.4× 94 0.9× 105 1.3× 32 680
Antonio R. Lucena‐Araujo Brazil 16 404 1.0× 153 0.5× 178 1.3× 151 1.5× 77 1.0× 62 750
Yuting Yi China 14 252 0.6× 192 0.7× 155 1.1× 114 1.1× 52 0.6× 54 631
Yang‐An Wen United States 13 498 1.2× 394 1.4× 109 0.8× 55 0.5× 71 0.9× 16 763
Mitsuhiro Hishida Japan 12 309 0.8× 152 0.5× 91 0.7× 82 0.8× 40 0.5× 23 484

Countries citing papers authored by Zhe Yang

Since Specialization
Citations

This map shows the geographic impact of Zhe Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhe Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhe Yang more than expected).

Fields of papers citing papers by Zhe Yang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zhe Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhe Yang. The network helps show where Zhe Yang may publish in the future.

Co-authorship network of co-authors of Zhe Yang

This figure shows the co-authorship network connecting the top 25 collaborators of Zhe Yang. A scholar is included among the top collaborators of Zhe Yang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zhe Yang. Zhe Yang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Shahzad, Asif, Wenjing Liu, Xiangjie Liu, et al.. (2025). Neutrophil extracellular traps and metabolic reprogramming in renal cell carcinoma: implications for tumor progression and immune-based therapeutics. Cancer Biology and Medicine. 22(11). 1–22. 1 indexed citations
2.
Shahzad, Asif, Yinfeng Yang, Wenjing Liu, et al.. (2025). Neutrophil Extracellular Traps (NETs) in health and disease. Molecular Biomedicine. 6(1). 130–130.
3.
4.
Kuang, Yingmin, Yu Huang, Jiaxin Niu, et al.. (2025). MTCH2 regulates NRF2-mediated RRM1 expression to promote melanoma proliferation and dacarbazine insensitivity. Cell Death and Disease. 16(1). 268–268.
5.
Xu, Shengjun, Qiang Wei, Xin Hu, et al.. (2024). No-touch recipient hepatectomy in liver transplantation for liver malignancies: A state-of-the-art review. Hepatobiliary & pancreatic diseases international. 24(1). 39–44. 2 indexed citations
6.
Shahzad, Asif, Muhammad Arfat Yameen, Wenjing Liu, et al.. (2024). Innovative lipid nanoparticles: A cutting-edge approach for potential renal cell carcinoma therapeutics. Biomedicine & Pharmacotherapy. 180. 117465–117465. 7 indexed citations
7.
Wu, Na, Yun Fang, Junlin Xie, et al.. (2024). Molecular mechanisms of MAZ targeting up-regulation of NDUFS3 expression to promote malignant progression in melanoma. Communications Biology. 7(1). 1491–1491.
8.
Shahzad, Asif, Wenjing Liu, Xiangjie Liu, et al.. (2024). Flavonoids as modulators of metabolic reprogramming in renal cell carcinoma (Review). Oncology Reports. 52(6). 2 indexed citations
9.
Li, Qian, Mei Liu, Yunxia Liu, et al.. (2024). Lethal Immune-Related Pneumonitis after Durvalumab Therapy for Small Cell Lung Cancer: A First Case in China. SHILAP Revista de lepidopterología. 17(1). 673–680.
10.
11.
Feng, Alei, Yanjun Li, Guangxu Li, et al.. (2022). Genomic Features of Organ-Specific Metastases in Lung Adenocarcinoma. Frontiers in Oncology. 12. 908759–908759. 7 indexed citations
12.
Wang, Shujie, Wenjing Liu, Lifeng Wang, et al.. (2021). Overexpression of ERCC3 is associated with poor prognosis in patients with pancreatic cancer. Journal of Cancer. 12(9). 2550–2559. 6 indexed citations
13.
Chen, Jing, Yun Fang, Zihan Yi, et al.. (2020). LINC00511 as a prognostic biomarker for human cancers: a systematic review and meta-analysis. BMC Cancer. 20(1). 682–682. 11 indexed citations
14.
Zheng, Shusen, Zhe Yang, & Yichao Wu. (2020). Liver transplantation for intrahepatic and perihilar cholangiocarcinoma: Current and future. Hepatobiliary & pancreatic diseases international. 19(2). 101–102. 3 indexed citations
15.
Zhang, Qiao, Zhe Yang, Qiaoqiao Han, et al.. (2020). NF-κB and pSTAT3 synergistically drive G6PD overexpression and facilitate sensitivity to G6PD inhibition in ccRCC. Cancer Cell International. 20(1). 483–483. 16 indexed citations
16.
Wu, Liming, Zhe Yang, Jie Zhang, et al.. (2018). Long noncoding RNA HOTTIP expression predicts tumor recurrence in hepatocellular carcinoma patients following liver transplantation. HepatoBiliary Surgery and Nutrition. 7(6). 429–439. 23 indexed citations
17.
Zhang, Qiao, Zhe Yang, Qiaoqiao Han, et al.. (2017). Overexpression of G6PD Represents a Potential Prognostic Factor in Clear Cell Renal Cell Carcinoma. Journal of Cancer. 8(4). 665–673. 35 indexed citations
18.
Jia, Linlin, Fengying Li, Wei Zhang, et al.. (2017). IL‑8 is upregulated in cervical cancer tissues and is associated with the proliferation and migration of HeLa cervical cancer cells. Oncology Letters. 15(1). 1350–1356. 24 indexed citations
19.
Zhang, Qiao, Zhe Yang, Qiaoqiao Han, et al.. (2017). G6PD promotes renal cell carcinoma proliferation through positive feedback regulation of p-STAT3. Oncotarget. 8(65). 109043–109060. 38 indexed citations
20.
Wu, Liming, Jiansong Ji, Zhe Yang, et al.. (2015). Oncogenic role of microRNA-423-5p in hepatocellular carcinoma. Hepatobiliary & pancreatic diseases international. 14(6). 613–618. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Guangyang Yu Breakdown of academic impact, for papers by Jingjing Zeng Breakdown of academic impact, for papers by Yingxi Mo Breakdown of academic impact, for papers by Chuanyong Zhang Breakdown of academic impact, for papers by Hubin Yin Breakdown of academic impact, for papers by Xiaoqian Jing Breakdown of academic impact, for papers by Antonio R. Lucena‐Araujo Breakdown of academic impact, for papers by Yuting Yi Breakdown of academic impact, for papers by Yang‐An Wen Breakdown of academic impact, for papers by Mitsuhiro Hishida
Rankless by CCL
2026